Benefits
Garcinol Antioxidant Activity
Garcinol from kokum scavenges free radicals in test-tube assays such as DPPH. No human trial of kokum has measured antioxidant status, so this is a laboratory property rather than a demonstrated effect in people. Kokum rind is also rich in anthocyanins, adding to the fruit's overall antioxidant profile and its traditional reputation as a cooling, restorative food.
Digestive and Traditional Use
Kokum has a long history in Indian cuisine and traditional practice as a digestive aid and soothing agent. It is used to support comfortable digestion. This rests on traditional culinary use. No human trial of kokum has measured a digestive outcome.
Weight-Management Interest (HCA)
Because Garcinia indica contains HCA, kokum is sometimes included in weight-management formulas. The human evidence comes from trials of Garcinia extract and HCA that were overwhelmingly Garcinia cambogia, a different species. The meta-analysis of those trials reported short-term weight loss of small magnitude and concluded that the clinical relevance is uncertain. No trial of Garcinia indica itself for weight loss is cited here.
Anti-Inflammatory Profile
In laboratory models garcinol helps modulate inflammatory signaling and enzymes involved in the inflammatory cascade. This may support a healthy inflammatory balance, but the evidence is preclinical rather than from human trials.
Mechanism of action
Free-Radical Scavenging
Garcinol and kokum anthocyanins donate electrons to quench DPPH and other free radicals in vitro and inhibit lipid peroxidation, underpinning the fruit's antioxidant reputation.
NF-κB and Inflammatory Enzyme Modulation
Garcinol suppresses NF-κB activation and downregulates inducible nitric oxide synthase, COX-2, and 5-lipoxygenase in laboratory models, reducing production of pro-inflammatory mediators such as prostaglandins and leukotrienes.
ATP-Citrate Lyase Inhibition (HCA)
The HCA fraction of Garcinia indica inhibits ATP-citrate lyase, the same fat-synthesis enzyme targeted by Garcinia cambogia HCA — the mechanistic basis for its weight-management positioning.
Clinical trials
Narrative review summarizing the phytochemistry and pharmacological activities of Garcinia indica (kokum), including garcinol and hydroxycitric acid.
Review of in vitro and animal studies. No human clinical trial of Garcinia indica is described in it.
The review describes antioxidant, anti-inflammatory, and other activities for kokum constituents, while noting that the evidence is preclinical and in vitro. No human clinical trial of Garcinia indica is reported anywhere in the review.
Systematic review and meta-analysis of randomized trials of Garcinia extract (HCA). Twelve of 23 identified trials met the inclusion criteria and nine had data that could be pooled. It is included here only because Garcinia indica also contains HCA.
Pooled across randomized trials of Garcinia extract and HCA. Those trials were overwhelmingly of Garcinia cambogia, a different species from Garcinia indica.
The authors concluded that randomized trials suggest Garcinia extracts and HCA can cause short-term weight loss, that the magnitude of the effect is small, and that the clinical relevance is uncertain. That conclusion concerns Garcinia cambogia extract in the main. Applying it to kokum is an inference from a shared constituent, not a result measured for kokum.